investorscraft@gmail.com

Intrinsic ValueBiON plc (BION.L)

Previous Close£0.15
Intrinsic Value
Upside potential
Previous Close
£0.15

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2020 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

BiON plc operates as a shell company with no significant ongoing operations, following its transition from Green & Smart Holdings plc in May 2020. Historically, the company was involved in industrial biotechnology, pollution control, and renewable energy, offering engineering consultancy, process design, and biogas power plant development. Its prior activities included wastewater treatment plant construction and maintenance, positioning it within the environmental technology and renewable energy sectors. However, the company’s current lack of operational focus places it in a precarious market position, with no clear revenue streams or competitive differentiation. The shift to a shell structure suggests strategic uncertainty, likely driven by financial challenges or restructuring efforts. Without active projects or a defined business model, BiON plc lacks the market presence or sector influence it once held in renewable energy infrastructure.

Revenue Profitability And Efficiency

In FY 2020, BiON plc reported revenue of 103.7 million GBp, but its net income was deeply negative at -121.6 million GBp, reflecting significant operational inefficiencies or discontinued activities. The diluted EPS of -0.28 GBp further underscores its unprofitability. Operating cash flow was negative at -12.9 million GBp, while capital expenditures totaled -36.5 million GBp, indicating limited reinvestment capacity.

Earnings Power And Capital Efficiency

The company’s negative earnings and cash flows highlight its inability to generate sustainable profits or deploy capital effectively. With no dividend payments and a lack of operational focus, BiON plc’s earnings power is effectively nonexistent, raising concerns about its long-term viability without strategic restructuring or new ventures.

Balance Sheet And Financial Health

BiON plc’s financial health is strained, with cash and equivalents of only 2.3 million GBp against total debt of 65.4 million GBp. This weak liquidity position, coupled with negative cash flows, suggests heightened solvency risks. The balance sheet reflects the challenges of transitioning from an active business to a shell company, with limited assets to support liabilities.

Growth Trends And Dividend Policy

The company exhibits no growth trajectory, given its inactive status and lack of revenue-generating operations. Its dividend policy is inactive, with no distributions in FY 2020, aligning with its non-operational shell structure. Historical data suggests a decline from its earlier renewable energy focus, with no clear path to revival.

Valuation And Market Expectations

With a market cap of approximately 1.1 million GBP and a beta of 0.66, BiON plc is priced as a high-risk, low-activity shell company. The market likely assigns minimal value to its residual assets, reflecting skepticism about its ability to re-enter operations or attract strategic interest.

Strategic Advantages And Outlook

BiON plc currently holds no discernible strategic advantages, given its dormant status. The outlook remains uncertain, contingent on potential restructuring, asset sales, or new business initiatives. Without a clear operational direction, the company faces significant challenges in regaining investor confidence or market relevance.

Sources

Company description, financial data from disclosed filings (FY 2020), and market data from LSE.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021202220232024202520262027202820292030203120322033203420352036203720382039204020412042204320442045

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount